| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |